CK19+/GPC3+ HCC has the highest risk of intrahepatic metastasis, microvascular invasion, regional lymph node involvement, and distant metastasis, followed by patients with the CK19−/GPC3+, and then CK19−/GPC3− phenotype. Here, GPC3 is linked to hepatocellular carcinoma.